Approval · Notice of Compliance 9894 · 2008
NIMBEX: Notice of Compliance 9894
Issued November 13, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9894
- Date
- November 13, 2008
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Deletion of clinical trial section and conversion of the product monograph to the new format
- Therapeutic class
- Non-depolarizing skeletal neuromuscular blocking agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NIMBEX | Not yet assigned | — |
Medicinal ingredients
- CISATRACURIUM BESYLATE 2 MG per ML